statistiche ricercatore

Continente	#
NA - Nord America	453
AS - Asia	268
EU - Europa	235
SA - Sud America	60
Continente sconosciuto - Info sul continente non disponibili	25
AF - Africa	20
OC - Oceania	1
Totale	1.062

Nazione	#
US - Stati Uniti d'America	430
CN - Cina	101
SG - Singapore	71
IT - Italia	52
IE - Irlanda	49
BR - Brasile	42
HK - Hong Kong	40
RU - Federazione Russa	30
DE - Germania	24
FI - Finlandia	19
VN - Vietnam	18
FR - Francia	14
GB - Regno Unito	13
ZA - Sudafrica	12
CA - Canada	11
AR - Argentina	10
IN - India	10
NL - Olanda	8
ES - Italia	5
UA - Ucraina	5
AT - Austria	4
KR - Corea	4
MA - Marocco	4
BD - Bangladesh	3
BE - Belgio	3
GT - Guatemala	3
IL - Israele	3
LV - Lettonia	3
MX - Messico	3
SE - Svezia	3
TR - Turchia	3
CW - ???statistics.table.value.countryCode.CW???	2
EC - Ecuador	2
ET - Etiopia	2
HN - Honduras	2
IQ - Iraq	2
PH - Filippine	2
PK - Pakistan	2
SV - El Salvador	2
AM - Armenia	1
AU - Australia	1
AZ - Azerbaigian	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
ID - Indonesia	1
IR - Iran	1
JO - Giordania	1
LB - Libano	1
LT - Lituania	1
ME - Montenegro	1
ML - Mali	1
PE - Perù	1
PS - Palestinian Territory	1
PY - Paraguay	1
SA - Arabia Saudita	1
SR - Suriname	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
VE - Venezuela	1
Totale	1.039

Nome	#
Interplay among nucleosomal DNA, histone tails, and corepressor CoREST underlies LSD1-mediated H3 demethylation.	182
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells	120
Discovery of Inhibitors for the Ether Lipid-Generating Enzyme AGPS as Anti-Cancer Agents	110
Altered modulation of lamin A/C-HDAC2 interaction and p21 expression during oxidative stress response in HGPS	109
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor	103
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer	101
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity	101
Targeting ROS production through inhibition of NADPH oxidases	89
Targeting ROS production through inhibition of NADPH oxidases	84
Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni	26
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML	19
Molecular Striptease of a Thiadiazolopyrimidine Hit Yields a Streamlined, Artifact-Free NADPH Mimic for NOX Inhibition	18
Totale	1.062

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	28	0	0	0	0	0	0	1	0	1	8	4	14
2022/2023	103	11	13	0	4	7	10	1	2	51	1	3	0
2023/2024	53	4	12	0	4	4	16	1	3	0	2	6	1
2024/2025	198	5	9	1	1	2	16	7	19	50	15	28	45
2025/2026	406	42	31	49	41	50	15	44	27	39	43	15	10
2026/2027	171	12	23	50	51	35	0	0	0	0	0	0	0
Totale													1.062